share_log

Merck & Co | 4: Statement of changes in beneficial ownership of securities-Officer Oosthuizen Johannes Jacobus

SEC announcement ·  Jan 25 05:21
Summary by Futu AI
Johannes Jacobus Oosthuizen, President of U.S. Market for Merck & Co., Inc. [MRK], completed a purchase of company stock on January 22, 2024. The transaction involved the acquisition of 3,133 shares of common stock at a price of $119.43 per share. Following this transaction, Oosthuizen's direct holdings in Merck & Co. increased to a total of 21,349.345 shares. The transaction is part of a grant, award, or other acquisition, as indicated by the transaction code 'A'. This purchase reflects a vote of confidence in the company's prospects and aligns the interests of management with those of shareholders.
Johannes Jacobus Oosthuizen, President of U.S. Market for Merck & Co., Inc. [MRK], completed a purchase of company stock on January 22, 2024. The transaction involved the acquisition of 3,133 shares of common stock at a price of $119.43 per share. Following this transaction, Oosthuizen's direct holdings in Merck & Co. increased to a total of 21,349.345 shares. The transaction is part of a grant, award, or other acquisition, as indicated by the transaction code 'A'. This purchase reflects a vote of confidence in the company's prospects and aligns the interests of management with those of shareholders.

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.